Sangyong Jon Selected Research

2-(trimethylsilyl)methyl acetate

6/2006

Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sangyong Jon Research Topics

Disease

58	Neoplasms (Cancer) 09/2022 - 04/2006
8	Inflammation (Inflammations) 01/2022 - 05/2010
8	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 11/2004
7	Body Weight (Weight, Body) 01/2020 - 04/2006
6	Breast Neoplasms (Breast Cancer) 11/2018 - 10/2011
3	Atherosclerosis 01/2018 - 05/2010
2	Melanoma (Melanoma, Malignant) 09/2022 - 04/2014
2	COVID-19 03/2022 - 01/2021
2	Reperfusion Injury 10/2021 - 01/2017
2	Disease Progression 10/2021 - 01/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 01/2021
2	Glioma (Gliomas) 01/2021 - 10/2013
2	Infections 01/2021 - 01/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 01/2018
2	Colitis 01/2020 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 09/2013
2	Lewis Lung Carcinoma 10/2012 - 10/2007
2	Hepatocellular Carcinoma (Hepatoma) 04/2011 - 06/2007
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2009 - 12/2007
1	Cytokine Release Syndrome 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Ischemia 10/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2021
1	Hepatitis B 05/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Human Influenza (Influenza) 01/2021

Drug/Important Bio-Agent (IBA)

27	Pharmaceutical PreparationsIBA 09/2022 - 10/2007
13	Peptides (Polypeptides)IBA 09/2022 - 03/2014
12	BilirubinIBA 01/2022 - 01/2016
11	LigandsIBA 07/2022 - 06/2006
10	AntigensIBA 01/2021 - 11/2004
10	Fibronectins (Fibronectin)IBA 01/2021 - 10/2012
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2018 - 10/2007
6	Contrast MediaIBA 01/2021 - 06/2006
6	Liposomes (Liposome)IBA 01/2021 - 07/2010
6	Coloring Agents (Dyes)IBA 01/2020 - 10/2007
5	Docetaxel (Taxotere)FDA Link 07/2022 - 04/2006
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2017
5	AntioxidantsIBA 10/2021 - 10/2017
5	APTIBA 01/2015 - 04/2006
5	Nucleotide AptamersIBA 11/2011 - 11/2004
4	CytokinesIBA 01/2022 - 05/2009
4	LipidsIBA 10/2021 - 01/2015
4	PolymersIBA 12/2018 - 11/2004
4	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2014
4	GoldIBA 08/2014 - 12/2007
3	Therapeutic UsesIBA 10/2021 - 01/2011
3	VaccinesIBA 01/2021 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	antineoplaston A10 (A 10)IBA 03/2011 - 04/2006
3	AminesIBA 01/2009 - 10/2007
2	CypateIBA 07/2022 - 06/2018
2	AntibodiesIBA 07/2022 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2017
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 10/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	NanovaccinesIBA 01/2020 - 08/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 03/2014
2	Ethylene Glycol (Monoethylene Glycol)IBA 08/2018 - 01/2009
2	CurcuminIBA 08/2018 - 01/2011
2	Lipid NanoparticlesIBA 01/2018 - 01/2016
2	Cell-Penetrating PeptidesIBA 01/2018 - 10/2017
2	CholesterolIBA 10/2017 - 01/2016
2	Exenatide (Byetta)FDA Link 01/2017 - 09/2013
2	KinesinsIBA 01/2016 - 02/2014
2	CY5.5 cyanine dyeIBA 01/2013 - 10/2007
2	Tumor Biomarkers (Tumor Markers)IBA 10/2012 - 11/2004
2	Dendrimers (Dendrons)IBA 11/2011 - 10/2011
1	VemurafenibIBA 09/2022
1	ChemokinesIBA 09/2022
1	Mannose (D-Mannose)IBA 07/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 07/2022
1	AcetylglucosamineIBA 07/2022
1	Isoantigens (Alloantigen)IBA 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2021
1	SolutionsIBA 05/2021
1	Viral DNAIBA 05/2021
1	Recombinases (Recombinase)IBA 05/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Angiotensin IIIBA 01/2020

Therapy/Procedure

35	Therapeutics 09/2022 - 10/2007
10	Intravenous Injections 10/2021 - 06/2006
6	Drug Therapy (Chemotherapy) 07/2022 - 04/2006
4	Immunotherapy 09/2022 - 08/2012
4	Lasers (Laser) 01/2021 - 01/2016
3	Photothermal Therapy 01/2021 - 10/2017
3	Precision Medicine 01/2020 - 02/2012
3	Aftercare (After-Treatment) 11/2018 - 01/2011
2	Quantum Dots (Quantum Dot) 04/2009 - 10/2007
1	Personal Protective Equipment 03/2022
1	Transplantation 01/2022